drugset / Trial / NCT01857297
A Study to Assess the Immunogenicity and Safety of CSL's 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This is a study to assess the immune (antibody) response and safety of the 2013/2014 formulation of Enzira® vaccine in healthy adult volunteers aged 18 years or older.
Timeline
- Start
- 2013-05
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enzira® Vaccine | Vaccine | 45 ug | Intramuscular |
| Subject | Enzira® Vaccine | Vaccine | 0.5 ml | Intramuscular |